博瑞医药股价跌5.04%，长城基金旗下1只基金重仓，持有2.83万股浮亏损失13.86万元

Group 1 - The core point of the news is that 博瑞医药 (Borui Pharmaceutical) experienced a decline of 5.04% in its stock price, reaching 92.13 yuan per share, with a trading volume of 784 million yuan and a turnover rate of 1.97%, resulting in a total market capitalization of 38.95 billion yuan [1] - 博瑞医药 is located in Suzhou Industrial Park, Jiangsu Province, and was established on October 26, 2001. The company went public on November 8, 2019, and its main business involves the research and production of high-end generic drugs and original new drugs [1] Group 2 - From the perspective of fund holdings, 长城基金 (Great Wall Fund) has one fund heavily invested in 博瑞医药. The 长城上证科创板100指数增强A (023446) fund held 28,300 shares in the second quarter, accounting for 1.85% of the fund's net value, making it the ninth largest holding. The estimated floating loss today is approximately 138,600 yuan [2] - The fund manager of 长城上证科创板100指数增强A is 雷俊 (Lei Jun), who has been in the position for 10 years and 263 days. The total asset size of the fund is 3.443 billion yuan, with the best fund return during his tenure being 153.3% and the worst being -89.53% [3]